Table 3.

Autonomic symptom scores based on EHR chart review data in NPD with genetic syndromes, individuals with ASD, and healthy controls.

	NPD			ASD			HC
	$\overline{x}$(σ)	Min	Max	$\overline{x}$(σ)	Min	Max	$\overline{x}$(σ)	Min	MaX	p-value
ACR Total	12.75(5.53)	0	28	11.47 (4.52)	3	31	2.46 (2.83)	0	16	ap=0.007* bp<0.0001** cp<0.0001**
Section I. Mood, Behavior, & Emotion (MBE)	4.53 (2.12)	0	8	5.82 (1.73)	1	8	0.50 (1.16)	0	6	ap<0.0001** bp<0.0001** cp<0.0001**
Section II. Secretomotor/Sensory Integration (SS)	1.74 (1.31)	0	6	1.42 (1.00)	0	5	0.34 (0.55)	0	3	ap=0.003* bp<0.0001** cp<0.0001**
Section III. Urinary/Gastrointestinal Systems (UG)	3.78 (2.45)	0	11	2.41 (1.95)	0	10	0.82 (1.11)	0	6	ap<0.0001** bp<0.0001** cp<0.0001**
Section IV. Circulation, Thermoregulatio n, Sleep Patterns, and Breathing (CTSB)	2.70 (2.02)	0	9	1.83 (1.62)	0	10	0.80 (1.19)	0	7	ap<0.0001** bp<0.0001** bp<0.0001**

Results from a multivariate analysis of variance (ANOVA) indicated a significant effect of Group on Autonomic symptom Total and sub-section scores (p’s<0.0001). Results from follow-up tests on between groups comparisons are reported in the table above.

^*p<0.01;

^**p<0.001